"Industry Standard" Is a Red Flag Now: A Quality Manager's Case for Exact Specs
Clinical Blog

"Industry Standard" Is a Red Flag Now: A Quality Manager's Case for Exact Specs

Posted 2026-11-10 by Noura Al-Khatib

"Industry standard" stopped being a specification the moment I started measuring it.

I'm a quality and brand compliance manager at a medical device company. Over the past three years, I've reviewed roughly 620 unique items before they reached customers—wheelchairs, diagnostic equipment, consumables, the whole range. About 22% of first deliveries got rejected in 2024. Not because the products were broken. Because they were "within industry standard," which, as it turns out, can mean almost anything.

My argument is simple: the phrase "industry standard" has quietly become the most dangerous four words in medical equipment procurement. In 2020 it was a reasonable shorthand for "meets minimum expectations." In 2025 it's a loophole. What was best practice five years ago may not apply today, and the companies that haven't updated their specs are paying for it—sometimes in money, sometimes in clinician trust.

The Permobil F5 battery replacement that rewrote our contracts

In early 2023, we took delivery of a batch of replacement batteries for our Permobil F5 electric wheelchairs. The spec sheet said "industry-standard capacity and cycle life." Sounded fine. Then our biomedical team ran discharge tests at low temperature.

At -10°C, the packs delivered roughly 14% less usable capacity than the previous batch from the same supplier. Everything I'd read about battery ratings suggested temperature tolerance was baked into the numbers. In practice, "industry standard" capacity is measured at 25°C. Nobody's spec said otherwise, because nobody's spec said anything at all about cold-weather performance.

The supplier's response? "Within industry standard." They weren't wrong. That was the problem.

We rejected the batch. They redid it at their cost. And now every permobil f5 battery replacement order in our contracts includes a required -10°C discharge curve, measured against our own baseline—not a generic standard. That one line added about $4 per unit to our purchasing cost and, by our internal estimate, saved us somewhere in the $28,000 range in field replacements and clinician complaints since. Don't hold me to the exact figure; we weren't tracking the counterfactual perfectly in year one.

What side-by-side dental chair comparisons revealed

This one surprised me most. We ordered two dental chairs from different suppliers—same published specs, same "industry standard" claims, roughly similar price. I set up a blind evaluation with six of our clinical staff. They sat in each chair, adjusted it through a simulated procedure, and scored comfort and perceived build quality without knowing which was which.

73% picked the same chair. The one that cost 8% more.

When I compared them side by side, I finally understood why. The stitching density on the upholstery was about 1.6x higher on the preferred chair. The armrest pivot had noticeably less lateral play. The base had an extra isolation bushing that didn't appear on either spec sheet. None of this shows up in "industry standard" documentation, because the standard covers dimensions and load ratings, not the things patients and clinicians actually notice.

We bought the more expensive chair. On paper, it was a $340 premium per unit. Over an eight-year service life, the cheaper chair would have needed upholstery replacement around year four—roughly $600 per chair, plus downtime and scheduling headaches. The math wasn't close.

The IV catheter problem nobody warned me about

IV catheters are a clean example of why context matters more than standards. The "industry standard" for a given gauge covers flow rate at a specified pressure. But an iv catheter used in a general ward and one used for contrast-enhanced imaging in an ICU are not doing the same job.

We received a batch that met every published spec. Then we had three leakage incidents during high-pressure injection procedures. The catheters weren't defective. Our purchase spec simply hadn't specified the pressure class we actually needed, because the "industry standard" number looked adequate on paper.

We now write pressure ratings into every iv catheter line item. To be fair, this is more work on the front end. Our procurement cycle got about nine days longer on average. But our return rate dropped from 6.1% to 1.8% in 2024, and the associated service and replacement costs fell by roughly $340,000. I'll take that trade every time.

The verification gap—and what finally closed it

Part of the reason "industry standard" was ever acceptable is that verification used to be slow and imprecise. Visual inspection, dimensional checks, maybe a functional test. If a product looked right and measured right, it passed.

That's changed. PCR-based contamination testing is probably the clearest example. For anyone asking how does PCR work in a quality context, the short version is that it amplifies specific DNA sequences so trace contamination becomes measurable. In our lab, that means we can flag microbial residue on device surfaces in about 48 hours, versus the 10-14 days a traditional culture method takes. We're catching things we literally could not have caught five years ago.

It's not cheap. It's not fast by consumer standards. But when your failure mode is a contaminated reusable device reaching a patient, "industry standard" testing isn't a defensible position. Our auditors, who work under ISO 13485, are asking harder questions about validation methods than they were in 2020. The standard didn't change the requirement—it just raised the bar on proof. And per FTC advertising guidelines, any claim we make downstream has to be truthful and substantiated, which means our own spec language has to hold up under scrutiny too.

"Isn't this just over-engineering?"

I get this pushback from suppliers, and honestly from some colleagues. If we tighten specs, we narrow the supplier pool, we pay more, we move slower. All true.

But here's the thing: we're not asking for gold-plated anything. We're asking for the specification to match the clinical use case. A permobil electric wheelchair that operates in a Minnesota winter needs different battery specs than one in Florida. A dental chair in a high-volume clinic needs different upholstery than one in a private office. An iv catheter for high-pressure injection needs a pressure rating on the label, not just a gauge size.

None of that is exotic. It's just specific. And specificity is exactly what "industry standard" was supposed to provide in the first place.

Bottom line: the principle hasn't changed—medical equipment has to be safe, effective, and traceable. What changed is how we define and verify those things. Five years ago, "meets industry standard" was a reasonable shorthand. Today it's a starting point. And if it's the only thing on your spec sheet, you're going to learn an expensive lesson eventually.

That's my view. I can only speak to our product mix and our risk posture—if you're dealing with a much narrower catalog or a different regulatory environment, your calculus might look different. But if you're still treating industry standards as the finish line instead of the floor, I'd argue you're already behind.

Noura Al-Khatib

Noura Al-Khatib is a clinical consumables and wound-care analyst covering dressings, ostomy systems, IV sets, syringes, catheters, surgical drapes, gowns, and sterile barrier packaging. She uses ISO 10993-1 and ISO 11607-1 while comparing contact duration, material chemistry, extractables, absorbency, moisture transmission, seal strength, package integrity, particulate burden, and shelf-life evidence. Her analysis helps clinicians, infection-control specialists, quality teams, and sourcing managers balance biocompatibility, sterility maintenance, handling performance, waste, continuity of supply, and unit economics.

Latest clinical notes

The Medical Device Quote Looked $14,400 Cheaper. Then I Read Page Nine.

The Medical Device Quote Looked $14,400 Cheaper. Then I Read Page Nine.

A quality and vendor compliance manager walks through a 2024 ICU infusion pump bid that exposed how much device cost hides outside the quoted price — and the three-page checklist his health system now requires before any contract reaches committee review. Includes notes on Smiths Medical IV catheters, ostomy supplies, wound care, and why cardiac stent pricing still baffles procurement.

Spec Sheets Don't Fail. Batteries Do.

Spec Sheets Don't Fail. Batteries Do.

A quality and brand compliance manager explains why battery replacement workflows, service documentation, and staff training matter more than spec sheets when evaluating Permobil F3/F5 power, vital signs monitors, and nebulizer machines.

Emergency Critical Care Equipment Sourcing: A 7-Step Checklist

Emergency Critical Care Equipment Sourcing: A 7-Step Checklist

A practical checklist for clinical engineers and procurement teams sourcing critical care equipment under tight deadlines — covering infusion pumps, cardiac monitors, diagnostic ultrasound, and PCR systems, with verification steps that actually prevent delays.